Hualan Biological Engineering (SZSE:002007) Cash-to-Debt : 3.89 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hualan Biological Engineering's cash to debt ratio for the quarter that ended in Mar. 2024 was 3.89.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Hualan Biological Engineering could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Hualan Biological Engineering's Cash-to-Debt or its related term are showing as below:

SZSE:002007' s Cash-to-Debt Range Over the Past 10 Years
Min: 3.08 Med: No Debt Max: No Debt
Current: 3.89

During the past 13 years, Hualan Biological Engineering's highest Cash to Debt Ratio was No Debt. The lowest was 3.08. And the median was No Debt.

SZSE:002007's Cash-to-Debt is ranked worse than
58.44% of 1540 companies
in the Biotechnology industry
Industry Median: 6.52 vs SZSE:002007: 3.89

Hualan Biological Engineering Cash-to-Debt Historical Data

The historical data trend for Hualan Biological Engineering's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Hualan Biological Engineering Cash-to-Debt Chart

Hualan Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

10.06

3.35

3.12

3.08

Hualan Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															3.20	3.09	3.52	3.08	3.89

Competitive Comparison of Hualan Biological Engineering's Cash-to-Debt

For the Biotechnology subindustry, Hualan Biological Engineering's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hualan Biological Engineering's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Cash-to-Debt falls into.

Hualan Biological Engineering Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Hualan Biological Engineering's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3108.593	/	(1000.706	+	9.148)
	=	3.08

Hualan Biological Engineering's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4319.368	/	(1100	+	9.226)
	=	3.89

Hualan Biological Engineering (SZSE:002007) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Hualan Biological Engineering Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines